Company Data
Regulus Therapeutics Inc.
Ticker
RGLS
Current Price
$7.915 134.87%
Market Cap
$524.3M
Price Target
Refer to Report
Volume
19.9M
52wk Range
$0.8301 - $3.73
Overview
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.